IUHSA
VRTX icon

Itau Unibanco Holding S.A.’s Vertex Pharmaceuticals VRTX Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70.5K Hold
142
– – ﹤0.01% 258
2026
Q1 		$63.4K Buy
142
+4
+3% +$1.86K ﹤0.01% 228
2025
Q4 		$62.6K Buy
138
+47
+52% +$20.3K ﹤0.01% 217
2025
Q3 		$35.6K Hold
91
– – ﹤0.01% 284
2025
Q2 		$40.5K Sell
91
-1
-1% -$461 ﹤0.01% 280
2025
Q1 		$45K Sell
92
-1
-1% -$466 ﹤0.01% 279
2024
Q4 		$37.5K Sell
93
-60
-39% -$27.8K ﹤0.01% 304
2024
Q3 		$71.2K Sell
153
-11
-7% -$5.28K ﹤0.01% 168
2024
Q2 		$76.9K Buy
+164
New +$71.2K ﹤0.01% 157
2024
Q1 		– Sell
-333
Closed -$135K – 357
2023
Q4 		$135K Sell
333
-424
-56% -$157K ﹤0.01% 164
2023
Q3 		$263K Buy
+757
New +$265K 0.01% 144
2023
Q1 		– Sell
-1,965
Closed -$568K – 617
2022
Q4 		$568K Buy
+1,965
New +$599K 0.02% 147
2022
Q1 		– Sell
-914
Closed -$203K – 554
2021
Q4 		$203K Buy
914
+225
+33% +$43.8K 0.01% 165
2021
Q3 		$125K Buy
689
+97
+16% +$18.9K 0.01% 168
2021
Q2 		$119K Buy
+592
New +$124K 0.01% 133
2020
Q1 		– Sell
-257
Closed -$56K – 876
2019
Q4 		$56K Sell
257
-70
-21% -$14.2K ﹤0.01% 663
2019
Q3 		$60K Hold
327
– – ﹤0.01% 232
2019
Q2 		$60K Buy
+327
New +$57.2K ﹤0.01% 549
2018
Q2 		– Sell
-2,771
Closed -$452K – 831
2018
Q1 		$452K Sell
2,771
-3,137
-53% -$512K ﹤0.01% 236
2017
Q4 		$885K Buy
5,908
+2,791
+90% +$413K 0.05% 99
2017
Q3 		$1.5M Buy
3,117
+3,067
+6,134% +$462K 0.1% 110
2017
Q2 		$6K Buy
+50
New +$6.02K ﹤0.01% 579

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Itau Unibanco Holding S.A.'s VRTX Position: Q2 2026 in Review

Itau Unibanco Holding S.A. held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 142 shares worth $70.5K. The position accounts for ﹤0.01% of the portfolio, ranked #258.

Itau Unibanco Holding S.A. first reported a position in VRTX in Q2 2017 and has held it in 22 quarters since. The position peaked at $1.5M in Q3 2017. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Itau Unibanco Holding S.A. held 142 shares of Vertex Pharmaceuticals worth $70.5K as of Q2 2026.
  • Itau Unibanco Holding S.A. left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up ﹤0.01% of Itau Unibanco Holding S.A.'s portfolio in Q2 2026, its #258 holding.
  • Itau Unibanco Holding S.A. first reported a position in Vertex Pharmaceuticals in Q2 2017 and has held it in 22 quarters since.
  • Itau Unibanco Holding S.A.'s Vertex Pharmaceuticals position peaked at $1.5M in Q3 2017.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q2 2026, filed 14 Aug 2026.